AlphAIAlphAI — Financial news for AI agents
stocktitan.netOCT 121 min read$USNA

Third-quarter results are set for Nov. 3; USANA's call follows the next morning.

USANA Health Sciences (USNA) will release Q3 2026 earnings on Nov. 3, followed by a conference call on Nov. 4. The company develops and sells nutritional supplements, functional foods, and personal care products.

Original reporting
stocktitan.net
Published Oct 12, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$USNA
Neutral
high confidence
Mentioned
$USNA
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$USNANeutralLow
01

Why it matters

The earnings‑date announcement provides a concrete timeline for market participants to plan trades around the upcoming Q3 results.

02

Market read

The news is a standard earnings‑release notice; relevance is modest but useful for timing‑sensitive traders.

03

What to watch

USANA's recent acquisitions (Hiya Health, Rise Wellness) may influence earnings expectations.

Relevance 5/10Novelty 5/10Timing: after‑market close on Nov 3, 2026; conference call on Nov 4

Background

USANA Health Sciences is a developer and manufacturer of nutritional supplements sold directly to consumers worldwide.

Company-level read

Ticker impact

$USNANeutralHigh confidence
Context

USANA Health Sciences announced the date and time for its Q3 2026 earnings release and accompanying conference call.

Expected impact

likely limited pressure as traders position ahead of the earnings release.

Evidence & confidence

Earnings date announcements are routine; they provide a clear timing cue but contain no new financial metrics.

Market effects

Sector

None beyond the nutrition supplements sector, which will watch USANA's results for peer benchmarking.

Regional

Limited to US‑listed health‑supplement stocks; no broader regional effect.

Global

Minimal, as USANA is a mid‑cap company with a niche product line.

Counterpoint

What could challenge this read

If investors expect a weak quarter, the earnings date could trigger short‑selling ahead of the release.

Key entities

  • company
    USANA Health Sciences, Inc.

    US‑listed nutrition‑supplement manufacturer (ticker USNA).

Read at source← All news

Related articles

AUG 12
$USNAMedAI 8/10

USANA (USNA) Q2 2026 Earnings Call Transcript

USANA (USNA) held its Q2 2026 earnings call. Management said Core Nutritional was stable, with Mainland China showing renewed strength. The company recorded a preliminary $29 million noncash goodwill impairment and $9 million income tax expense on a $19 million pretax loss. USANA ended the quarter with $169 million cash, zero debt, and $20 million free cash flow, and lowered its fiscal 2026 outlook due to HYA DTC marketing and Rise net sales.

yahoo.com6 min
AUG 11
$USNAMedAI 8/10

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences (NYSE:USNA) reported Q2 updates including a $29 million preliminary non-cash goodwill impairment tied to its Hiya reporting unit and $9 million income tax expense on a $19 million pre-tax loss. Management cited about $30 million to $40 million top-line pressure and $4 million to $5 million margin pressure, plus a Rise packaging disruption. USANA ended with $169 million cash and no debt.

yahoo.com6 min
AUG 9
$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

yahoo.com6 min
AUG 4
$USNAHigh

USANA Health Sciences Reports Second Quarter 2026 Results

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fisca

SEC EDGAR 8-K6 min